カテゴリー： Market Monitor Global, 世界, 医療/バイオ

麻疹・おたふく風邪・風疹ウイルスワクチンの世界市場見通し2023年-2029年

◆英語タイトル：Measles, Mumps, and Rubella Virus Vaccine Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5741）

◆商品コード：MMG23JU5741
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月（※2025年版があります。お問い合わせください。）
◆ページ数：70
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥468,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥608,400	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥702,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Measles, Mumps, and Rubella Virus Vaccine Market 調査レポートは次の情報を含め、グローバルにおけるの麻疹・おたふく風邪・風疹ウイルスワクチン市場規模と予測を収録しています。・世界の麻疹・おたふく風邪・風疹ウイルスワクチン市場：売上、2018年-2023年、2024年-2029年
・世界の麻疹・おたふく風邪・風疹ウイルスワクチン市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の麻疹・おたふく風邪・風疹ウイルスワクチン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「子供」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

麻疹・おたふく風邪・風疹ウイルスワクチンのグローバル主要企業は、Merck、 Tiantan Bio、 Minhai Bio、 Lanzhou Institute、 Beijing Bio-Instituteなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、麻疹・おたふく風邪・風疹ウイルスワクチンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の麻疹・おたふく風邪・風疹ウイルスワクチン市場：タイプ別、2018年-2023年、2024年-2029年
世界の麻疹・おたふく風邪・風疹ウイルスワクチン市場：タイプ別市場シェア、2022年
・子供、大人

世界の麻疹・おたふく風邪・風疹ウイルスワクチン市場：用途別、2018年-2023年、2024年-2029年
世界の麻疹・おたふく風邪・風疹ウイルスワクチン市場：用途別市場シェア、2022年
・公立、私立

世界の麻疹・おたふく風邪・風疹ウイルスワクチン市場：地域・国別、2018年-2023年、2024年-2029年
世界の麻疹・おたふく風邪・風疹ウイルスワクチン市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における麻疹・おたふく風邪・風疹ウイルスワクチンのグローバル売上、2018年-2023年
・主要企業における麻疹・おたふく風邪・風疹ウイルスワクチンのグローバル売上シェア、2022年
・主要企業における麻疹・おたふく風邪・風疹ウイルスワクチンのグローバル販売量、2018年-2023年
・主要企業における麻疹・おたふく風邪・風疹ウイルスワクチンのグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Merck、 Tiantan Bio、 Minhai Bio、 Lanzhou Institute、 Beijing Bio-Institute

*************************************************************

・調査・分析レポートの概要
麻疹・おたふく風邪・風疹ウイルスワクチン市場の定義
市場セグメント
世界の麻疹・おたふく風邪・風疹ウイルスワクチン市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の麻疹・おたふく風邪・風疹ウイルスワクチン市場規模
世界の麻疹・おたふく風邪・風疹ウイルスワクチン市場規模：2022年 VS 2029年
世界の麻疹・おたふく風邪・風疹ウイルスワクチン市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの麻疹・おたふく風邪・風疹ウイルスワクチンの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の麻疹・おたふく風邪・風疹ウイルスワクチン製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：子供、大人
麻疹・おたふく風邪・風疹ウイルスワクチンのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：公立、私立
麻疹・おたふく風邪・風疹ウイルスワクチンの用途別グローバル売上・予測

・地域別市場分析
地域別麻疹・おたふく風邪・風疹ウイルスワクチン市場規模 2022年と2029年
地域別麻疹・おたふく風邪・風疹ウイルスワクチン売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Merck、 Tiantan Bio、 Minhai Bio、 Lanzhou Institute、 Beijing Bio-Institute
...

The MMR vaccine is a vaccine against measles, mumps, and rubella (German measles).
This report aims to provide a comprehensive presentation of the global market for Measles, Mumps, and Rubella Virus Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Measles, Mumps, and Rubella Virus Vaccine. This report contains market size and forecasts of Measles, Mumps, and Rubella Virus Vaccine in global, including the following market information:
Global Measles, Mumps, and Rubella Virus Vaccine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Measles, Mumps, and Rubella Virus Vaccine Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Measles, Mumps, and Rubella Virus Vaccine companies in 2022 (%)
The global Measles, Mumps, and Rubella Virus Vaccine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Child Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Measles, Mumps, and Rubella Virus Vaccine include Merck, Tiantan Bio, Minhai Bio, Lanzhou Institute and Beijing Bio-Institute, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Measles, Mumps, and Rubella Virus Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Measles, Mumps, and Rubella Virus Vaccine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Measles, Mumps, and Rubella Virus Vaccine Market Segment Percentages, by Type, 2022 (%)
Child
Adult
Global Measles, Mumps, and Rubella Virus Vaccine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Measles, Mumps, and Rubella Virus Vaccine Market Segment Percentages, by Application, 2022 (%)
Public
Private
Global Measles, Mumps, and Rubella Virus Vaccine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Measles, Mumps, and Rubella Virus Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Measles, Mumps, and Rubella Virus Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Measles, Mumps, and Rubella Virus Vaccine revenues share in global market, 2022 (%)
Key companies Measles, Mumps, and Rubella Virus Vaccine sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Measles, Mumps, and Rubella Virus Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Tiantan Bio
Minhai Bio
Lanzhou Institute
Beijing Bio-Institute
Outline of Major Chapters:
Chapter 1: Introduces the definition of Measles, Mumps, and Rubella Virus Vaccine, market overview.
Chapter 2: Global Measles, Mumps, and Rubella Virus Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Measles, Mumps, and Rubella Virus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Measles, Mumps, and Rubella Virus Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Measles, Mumps, and Rubella Virus Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Measles, Mumps, and Rubella Virus Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Measles, Mumps, and Rubella Virus Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Measles, Mumps, and Rubella Virus Vaccine Overall Market Size
2.1 Global Measles, Mumps, and Rubella Virus Vaccine Market Size: 2022 VS 2029
2.2 Global Measles, Mumps, and Rubella Virus Vaccine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Measles, Mumps, and Rubella Virus Vaccine Sales: 2018-2029
3 Company Landscape
3.1 Top Measles, Mumps, and Rubella Virus Vaccine Players in Global Market
3.2 Top Global Measles, Mumps, and Rubella Virus Vaccine Companies Ranked by Revenue
3.3 Global Measles, Mumps, and Rubella Virus Vaccine Revenue by Companies
3.4 Global Measles, Mumps, and Rubella Virus Vaccine Sales by Companies
3.5 Global Measles, Mumps, and Rubella Virus Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Measles, Mumps, and Rubella Virus Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Measles, Mumps, and Rubella Virus Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Measles, Mumps, and Rubella Virus Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Measles, Mumps, and Rubella Virus Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Measles, Mumps, and Rubella Virus Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Measles, Mumps, and Rubella Virus Vaccine Market Size Markets, 2022 & 2029
4.1.2 Child
4.1.3 Adult
4.2 By Type – Global Measles, Mumps, and Rubella Virus Vaccine Revenue & Forecasts
4.2.1 By Type – Global Measles, Mumps, and Rubella Virus Vaccine Revenue, 2018-2023
4.2.2 By Type – Global Measles, Mumps, and Rubella Virus Vaccine Revenue, 2024-2029
4.2.3 By Type – Global Measles, Mumps, and Rubella Virus Vaccine Revenue Market Share, 2018-2029
4.3 By Type – Global Measles, Mumps, and Rubella Virus Vaccine Sales & Forecasts
4.3.1 By Type – Global Measles, Mumps, and Rubella Virus Vaccine Sales, 2018-2023
4.3.2 By Type – Global Measles, Mumps, and Rubella Virus Vaccine Sales, 2024-2029
4.3.3 By Type – Global Measles, Mumps, and Rubella Virus Vaccine Sales Market Share, 2018-2029
4.4 By Type – Global Measles, Mumps, and Rubella Virus Vaccine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Measles, Mumps, and Rubella Virus Vaccine Market Size, 2022 & 2029
5.1.2 Public
5.1.3 Private
5.2 By Application – Global Measles, Mumps, and Rubella Virus Vaccine Revenue & Forecasts
5.2.1 By Application – Global Measles, Mumps, and Rubella Virus Vaccine Revenue, 2018-2023
5.2.2 By Application – Global Measles, Mumps, and Rubella Virus Vaccine Revenue, 2024-2029
5.2.3 By Application – Global Measles, Mumps, and Rubella Virus Vaccine Revenue Market Share, 2018-2029
5.3 By Application – Global Measles, Mumps, and Rubella Virus Vaccine Sales & Forecasts
5.3.1 By Application – Global Measles, Mumps, and Rubella Virus Vaccine Sales, 2018-2023
5.3.2 By Application – Global Measles, Mumps, and Rubella Virus Vaccine Sales, 2024-2029
5.3.3 By Application – Global Measles, Mumps, and Rubella Virus Vaccine Sales Market Share, 2018-2029
5.4 By Application – Global Measles, Mumps, and Rubella Virus Vaccine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Measles, Mumps, and Rubella Virus Vaccine Market Size, 2022 & 2029
6.2 By Region – Global Measles, Mumps, and Rubella Virus Vaccine Revenue & Forecasts
6.2.1 By Region – Global Measles, Mumps, and Rubella Virus Vaccine Revenue, 2018-2023
6.2.2 By Region – Global Measles, Mumps, and Rubella Virus Vaccine Revenue, 2024-2029
6.2.3 By Region – Global Measles, Mumps, and Rubella Virus Vaccine Revenue Market Share, 2018-2029
6.3 By Region – Global Measles, Mumps, and Rubella Virus Vaccine Sales & Forecasts
6.3.1 By Region – Global Measles, Mumps, and Rubella Virus Vaccine Sales, 2018-2023
6.3.2 By Region – Global Measles, Mumps, and Rubella Virus Vaccine Sales, 2024-2029
6.3.3 By Region – Global Measles, Mumps, and Rubella Virus Vaccine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Measles, Mumps, and Rubella Virus Vaccine Revenue, 2018-2029
6.4.2 By Country – North America Measles, Mumps, and Rubella Virus Vaccine Sales, 2018-2029
6.4.3 US Measles, Mumps, and Rubella Virus Vaccine Market Size, 2018-2029
6.4.4 Canada Measles, Mumps, and Rubella Virus Vaccine Market Size, 2018-2029
6.4.5 Mexico Measles, Mumps, and Rubella Virus Vaccine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Measles, Mumps, and Rubella Virus Vaccine Revenue, 2018-2029
6.5.2 By Country – Europe Measles, Mumps, and Rubella Virus Vaccine Sales, 2018-2029
6.5.3 Germany Measles, Mumps, and Rubella Virus Vaccine Market Size, 2018-2029
6.5.4 France Measles, Mumps, and Rubella Virus Vaccine Market Size, 2018-2029
6.5.5 U.K. Measles, Mumps, and Rubella Virus Vaccine Market Size, 2018-2029
6.5.6 Italy Measles, Mumps, and Rubella Virus Vaccine Market Size, 2018-2029
6.5.7 Russia Measles, Mumps, and Rubella Virus Vaccine Market Size, 2018-2029
6.5.8 Nordic Countries Measles, Mumps, and Rubella Virus Vaccine Market Size, 2018-2029
6.5.9 Benelux Measles, Mumps, and Rubella Virus Vaccine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Measles, Mumps, and Rubella Virus Vaccine Revenue, 2018-2029
6.6.2 By Region – Asia Measles, Mumps, and Rubella Virus Vaccine Sales, 2018-2029
6.6.3 China Measles, Mumps, and Rubella Virus Vaccine Market Size, 2018-2029
6.6.4 Japan Measles, Mumps, and Rubella Virus Vaccine Market Size, 2018-2029
6.6.5 South Korea Measles, Mumps, and Rubella Virus Vaccine Market Size, 2018-2029
6.6.6 Southeast Asia Measles, Mumps, and Rubella Virus Vaccine Market Size, 2018-2029
6.6.7 India Measles, Mumps, and Rubella Virus Vaccine Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Measles, Mumps, and Rubella Virus Vaccine Revenue, 2018-2029
6.7.2 By Country – South America Measles, Mumps, and Rubella Virus Vaccine Sales, 2018-2029
6.7.3 Brazil Measles, Mumps, and Rubella Virus Vaccine Market Size, 2018-2029
6.7.4 Argentina Measles, Mumps, and Rubella Virus Vaccine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Measles, Mumps, and Rubella Virus Vaccine Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Measles, Mumps, and Rubella Virus Vaccine Sales, 2018-2029
6.8.3 Turkey Measles, Mumps, and Rubella Virus Vaccine Market Size, 2018-2029
6.8.4 Israel Measles, Mumps, and Rubella Virus Vaccine Market Size, 2018-2029
6.8.5 Saudi Arabia Measles, Mumps, and Rubella Virus Vaccine Market Size, 2018-2029
6.8.6 UAE Measles, Mumps, and Rubella Virus Vaccine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck Measles, Mumps, and Rubella Virus Vaccine Major Product Offerings
7.1.4 Merck Measles, Mumps, and Rubella Virus Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 Merck Key News & Latest Developments
7.2 Tiantan Bio
7.2.1 Tiantan Bio Company Summary
7.2.2 Tiantan Bio Business Overview
7.2.3 Tiantan Bio Measles, Mumps, and Rubella Virus Vaccine Major Product Offerings
7.2.4 Tiantan Bio Measles, Mumps, and Rubella Virus Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 Tiantan Bio Key News & Latest Developments
7.3 Minhai Bio
7.3.1 Minhai Bio Company Summary
7.3.2 Minhai Bio Business Overview
7.3.3 Minhai Bio Measles, Mumps, and Rubella Virus Vaccine Major Product Offerings
7.3.4 Minhai Bio Measles, Mumps, and Rubella Virus Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 Minhai Bio Key News & Latest Developments
7.4 Lanzhou Institute
7.4.1 Lanzhou Institute Company Summary
7.4.2 Lanzhou Institute Business Overview
7.4.3 Lanzhou Institute Measles, Mumps, and Rubella Virus Vaccine Major Product Offerings
7.4.4 Lanzhou Institute Measles, Mumps, and Rubella Virus Vaccine Sales and Revenue in Global (2018-2023)
7.4.5 Lanzhou Institute Key News & Latest Developments
7.5 Beijing Bio-Institute
7.5.1 Beijing Bio-Institute Company Summary
7.5.2 Beijing Bio-Institute Business Overview
7.5.3 Beijing Bio-Institute Measles, Mumps, and Rubella Virus Vaccine Major Product Offerings
7.5.4 Beijing Bio-Institute Measles, Mumps, and Rubella Virus Vaccine Sales and Revenue in Global (2018-2023)
7.5.5 Beijing Bio-Institute Key News & Latest Developments
8 Global Measles, Mumps, and Rubella Virus Vaccine Production Capacity, Analysis
8.1 Global Measles, Mumps, and Rubella Virus Vaccine Production Capacity, 2018-2029
8.2 Measles, Mumps, and Rubella Virus Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Measles, Mumps, and Rubella Virus Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Measles, Mumps, and Rubella Virus Vaccine Supply Chain Analysis
10.1 Measles, Mumps, and Rubella Virus Vaccine Industry Value Chain
10.2 Measles, Mumps, and Rubella Virus Vaccine Upstream Market
10.3 Measles, Mumps, and Rubella Virus Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Measles, Mumps, and Rubella Virus Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Measles, Mumps, and Rubella Virus Vaccine in Global Market
Table 2. Top Measles, Mumps, and Rubella Virus Vaccine Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Measles, Mumps, and Rubella Virus Vaccine Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Measles, Mumps, and Rubella Virus Vaccine Revenue Share by Companies, 2018-2023
Table 5. Global Measles, Mumps, and Rubella Virus Vaccine Sales by Companies, (K Units), 2018-2023
Table 6. Global Measles, Mumps, and Rubella Virus Vaccine Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Measles, Mumps, and Rubella Virus Vaccine Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Measles, Mumps, and Rubella Virus Vaccine Product Type
Table 9. List of Global Tier 1 Measles, Mumps, and Rubella Virus Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Measles, Mumps, and Rubella Virus Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Measles, Mumps, and Rubella Virus Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Measles, Mumps, and Rubella Virus Vaccine Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Measles, Mumps, and Rubella Virus Vaccine Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Measles, Mumps, and Rubella Virus Vaccine Sales (K Units), 2018-2023
Table 15. By Type - Global Measles, Mumps, and Rubella Virus Vaccine Sales (K Units), 2024-2029
Table 16. By Application – Global Measles, Mumps, and Rubella Virus Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Measles, Mumps, and Rubella Virus Vaccine Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Measles, Mumps, and Rubella Virus Vaccine Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Measles, Mumps, and Rubella Virus Vaccine Sales (K Units), 2018-2023
Table 20. By Application - Global Measles, Mumps, and Rubella Virus Vaccine Sales (K Units), 2024-2029
Table 21. By Region – Global Measles, Mumps, and Rubella Virus Vaccine Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Measles, Mumps, and Rubella Virus Vaccine Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Measles, Mumps, and Rubella Virus Vaccine Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Measles, Mumps, and Rubella Virus Vaccine Sales (K Units), 2018-2023
Table 25. By Region - Global Measles, Mumps, and Rubella Virus Vaccine Sales (K Units), 2024-2029
Table 26. By Country - North America Measles, Mumps, and Rubella Virus Vaccine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Measles, Mumps, and Rubella Virus Vaccine Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Measles, Mumps, and Rubella Virus Vaccine Sales, (K Units), 2018-2023
Table 29. By Country - North America Measles, Mumps, and Rubella Virus Vaccine Sales, (K Units), 2024-2029
Table 30. By Country - Europe Measles, Mumps, and Rubella Virus Vaccine Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Measles, Mumps, and Rubella Virus Vaccine Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Measles, Mumps, and Rubella Virus Vaccine Sales, (K Units), 2018-2023
Table 33. By Country - Europe Measles, Mumps, and Rubella Virus Vaccine Sales, (K Units), 2024-2029
Table 34. By Region - Asia Measles, Mumps, and Rubella Virus Vaccine Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Measles, Mumps, and Rubella Virus Vaccine Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Measles, Mumps, and Rubella Virus Vaccine Sales, (K Units), 2018-2023
Table 37. By Region - Asia Measles, Mumps, and Rubella Virus Vaccine Sales, (K Units), 2024-2029
Table 38. By Country - South America Measles, Mumps, and Rubella Virus Vaccine Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Measles, Mumps, and Rubella Virus Vaccine Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Measles, Mumps, and Rubella Virus Vaccine Sales, (K Units), 2018-2023
Table 41. By Country - South America Measles, Mumps, and Rubella Virus Vaccine Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Measles, Mumps, and Rubella Virus Vaccine Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Measles, Mumps, and Rubella Virus Vaccine Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Measles, Mumps, and Rubella Virus Vaccine Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Measles, Mumps, and Rubella Virus Vaccine Sales, (K Units), 2024-2029
Table 46. Merck Company Summary
Table 47. Merck Measles, Mumps, and Rubella Virus Vaccine Product Offerings
Table 48. Merck Measles, Mumps, and Rubella Virus Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Merck Key News & Latest Developments
Table 50. Tiantan Bio Company Summary
Table 51. Tiantan Bio Measles, Mumps, and Rubella Virus Vaccine Product Offerings
Table 52. Tiantan Bio Measles, Mumps, and Rubella Virus Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Tiantan Bio Key News & Latest Developments
Table 54. Minhai Bio Company Summary
Table 55. Minhai Bio Measles, Mumps, and Rubella Virus Vaccine Product Offerings
Table 56. Minhai Bio Measles, Mumps, and Rubella Virus Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Minhai Bio Key News & Latest Developments
Table 58. Lanzhou Institute Company Summary
Table 59. Lanzhou Institute Measles, Mumps, and Rubella Virus Vaccine Product Offerings
Table 60. Lanzhou Institute Measles, Mumps, and Rubella Virus Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Lanzhou Institute Key News & Latest Developments
Table 62. Beijing Bio-Institute Company Summary
Table 63. Beijing Bio-Institute Measles, Mumps, and Rubella Virus Vaccine Product Offerings
Table 64. Beijing Bio-Institute Measles, Mumps, and Rubella Virus Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Beijing Bio-Institute Key News & Latest Developments
Table 66. Measles, Mumps, and Rubella Virus Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 67. Global Measles, Mumps, and Rubella Virus Vaccine Capacity Market Share of Key Manufacturers, 2021-2023
Table 68. Global Measles, Mumps, and Rubella Virus Vaccine Production by Region, 2018-2023 (K Units)
Table 69. Global Measles, Mumps, and Rubella Virus Vaccine Production by Region, 2024-2029 (K Units)
Table 70. Measles, Mumps, and Rubella Virus Vaccine Market Opportunities & Trends in Global Market
Table 71. Measles, Mumps, and Rubella Virus Vaccine Market Drivers in Global Market
Table 72. Measles, Mumps, and Rubella Virus Vaccine Market Restraints in Global Market
Table 73. Measles, Mumps, and Rubella Virus Vaccine Raw Materials
Table 74. Measles, Mumps, and Rubella Virus Vaccine Raw Materials Suppliers in Global Market
Table 75. Typical Measles, Mumps, and Rubella Virus Vaccine Downstream
Table 76. Measles, Mumps, and Rubella Virus Vaccine Downstream Clients in Global Market
Table 77. Measles, Mumps, and Rubella Virus Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Measles, Mumps, and Rubella Virus Vaccine Segment by Type in 2022
Figure 2. Measles, Mumps, and Rubella Virus Vaccine Segment by Application in 2022
Figure 3. Global Measles, Mumps, and Rubella Virus Vaccine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Measles, Mumps, and Rubella Virus Vaccine Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Measles, Mumps, and Rubella Virus Vaccine Revenue, 2018-2029 (US$, Mn)
Figure 7. Measles, Mumps, and Rubella Virus Vaccine Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Measles, Mumps, and Rubella Virus Vaccine Revenue in 2022
Figure 9. By Type - Global Measles, Mumps, and Rubella Virus Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Measles, Mumps, and Rubella Virus Vaccine Revenue Market Share, 2018-2029
Figure 11. By Type - Global Measles, Mumps, and Rubella Virus Vaccine Sales Market Share, 2018-2029
Figure 12. By Type - Global Measles, Mumps, and Rubella Virus Vaccine Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Measles, Mumps, and Rubella Virus Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Measles, Mumps, and Rubella Virus Vaccine Revenue Market Share, 2018-2029
Figure 15. By Application - Global Measles, Mumps, and Rubella Virus Vaccine Sales Market Share, 2018-2029
Figure 16. By Application - Global Measles, Mumps, and Rubella Virus Vaccine Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Measles, Mumps, and Rubella Virus Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Measles, Mumps, and Rubella Virus Vaccine Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Measles, Mumps, and Rubella Virus Vaccine Revenue Market Share, 2018-2029
Figure 20. By Region - Global Measles, Mumps, and Rubella Virus Vaccine Sales Market Share, 2018-2029
Figure 21. By Country - North America Measles, Mumps, and Rubella Virus Vaccine Revenue Market Share, 2018-2029
Figure 22. By Country - North America Measles, Mumps, and Rubella Virus Vaccine Sales Market Share, 2018-2029
Figure 23. US Measles, Mumps, and Rubella Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Measles, Mumps, and Rubella Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Measles, Mumps, and Rubella Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Measles, Mumps, and Rubella Virus Vaccine Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Measles, Mumps, and Rubella Virus Vaccine Sales Market Share, 2018-2029
Figure 28. Germany Measles, Mumps, and Rubella Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 29. France Measles, Mumps, and Rubella Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Measles, Mumps, and Rubella Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Measles, Mumps, and Rubella Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Measles, Mumps, and Rubella Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Measles, Mumps, and Rubella Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Measles, Mumps, and Rubella Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Measles, Mumps, and Rubella Virus Vaccine Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Measles, Mumps, and Rubella Virus Vaccine Sales Market Share, 2018-2029
Figure 37. China Measles, Mumps, and Rubella Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Measles, Mumps, and Rubella Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Measles, Mumps, and Rubella Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Measles, Mumps, and Rubella Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 41. India Measles, Mumps, and Rubella Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Measles, Mumps, and Rubella Virus Vaccine Revenue Market Share, 2018-2029
Figure 43. By Country - South America Measles, Mumps, and Rubella Virus Vaccine Sales Market Share, 2018-2029
Figure 44. Brazil Measles, Mumps, and Rubella Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Measles, Mumps, and Rubella Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Measles, Mumps, and Rubella Virus Vaccine Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Measles, Mumps, and Rubella Virus Vaccine Sales Market Share, 2018-2029
Figure 48. Turkey Measles, Mumps, and Rubella Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Measles, Mumps, and Rubella Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Measles, Mumps, and Rubella Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Measles, Mumps, and Rubella Virus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 52. Global Measles, Mumps, and Rubella Virus Vaccine Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Measles, Mumps, and Rubella Virus Vaccine by Region, 2022 VS 2029
Figure 54. Measles, Mumps, and Rubella Virus Vaccine Industry Value Chain
Figure 55. Marketing Channels

※参考情報

麻疹・おたふく風邪・風疹ウイルスワクチン（MMRワクチン）は、麻疹、風疹、おたふく風邪の三つの病気に対する予防接種用ワクチンです。このワクチンは、特に小児期におけるこれらの感染症の発生を防ぐために広く使用されています。以下では、MMRワクチンの定義、特徴、種類、用途、関連技術などについて詳しく説明致します。

MMRワクチンは、いずれもウイルス性の感染症を引き起こす病原体に対して作られた生ワクチンです。麻疹、風疹、おたふく風邪は、いずれも非常に感染力が高く、重篤な合併症を引き起こす可能性があるため、予防接種が非常に重要です。麻疹は高熱と発疹を伴う感染症で、肺炎や脳炎などの合併症を引き起こすことがあります。風疹は、特に妊婦にとってリスクが高く、胎児に先天性風疹症候群を引き起こすことが知られています。おたふく風邪は、耳下腺の腫れを引き起こす病気で、成人の場合は精巣炎や無精子症の原因となることがあります。

MMRワクチンの特徴としては、通常、1回の接種で3つの疾患に対して同時に免疫を獲得できるため、接種回数の減少に寄与します。また、ワクチンの効果は非常に高いとされており、多くの国でアウトブレイクを防ぐために重要な役割を果たしています。例えば、麻疹に関しては、ワクチン接種率が高い国ではほとんど症例が報告されていないことが多いです。

MMRワクチンの種類には、一般的に「生ワクチン」として知られるタイプが存在します。生ワクチンは、病原体を弱毒化したものを使用しており、体内で感染を模倣することにより免疫応答を引き起こします。このような疫学的背景により、ワクチンに含まれているウイルスは活性を持っているが、病気の原因となるほどの病原性が低く、免疫系を適切に刺激することができます。

MMRワクチンの主な用途は、これらの感染症からの予防ですが、特にワクチン接種は集団免疫を形成する助けともなります。集団免疫は、多くの人々がワクチンを接種することで、病気の伝播を防ぐ効果を指します。このため、MMRワクチンは世界中の公衆衛生政策の一環として推奨されており、特に幼児期における定期接種のプログラムの中で位置付けられています。

関連技術としては、ワクチンの保存技術や、接種後の免疫応答を調べるための技術が挙げられます。冷蔵保存が必要なMMRワクチンは、適切な温度での管理が不可欠であり、これを適切に行うための技術進歩も進んでいます。また、ワクチンの効果を検証するために、抗体価検査などの技術も用いられています。このような検査は、個々の接種者の免疫状態を確認し、必要に応じて追加接種を行う際にも重要です。

MMRワクチンは、接種後に軽微な副反応を示すことがあります。一般的な副反応には、発熱、発疹、腺の腫れなどがあり、これらは通常は自己限局性であり、重篤な健康問題を引き起こすことは稀です。ただし、重篤なアレルギー反応や、他の稀な副反応が報告されることがあるため、接種前には医療機関での評価が重要です。

さらに、母体から胎児への影響や、その他のワクチンとの併用に関する研究も進められており、安全性の確認は引き続き重要なテーマであります。ワクチンの開発、製造、流通に関しても、規制当局が厳しい基準を設けており、これに基づいて監視や評価が行われています。

結論として、麻疹・おたふく風邪・風疹ウイルスワクチン（MMRワクチン）は、これらの感染症予防において非常に効果的であり、多くの国で定期接種プログラムに組み込まれています。接種により多くの命が救われ、感染症の蔓延が防がれています。今後もワクチンに関する研究や技術の進歩が期待され、さらなる公衆衛生の向上に寄与することが期待されています。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 麻疹・おたふく風邪・風疹ウイルスワクチンの世界市場見通し2023年-2029年(Measles, Mumps, and Rubella Virus Vaccine Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

麻疹・おたふく風邪・風疹ウイルスワクチンの世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp